← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Elucid
Boston, MA
$4,568,969
Total funding
1
Grants
Funding over time
peak $1M · FY2015–21$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,568,969 · 1
By mechanism
R44$4,568,969 · 1
Investigators at Elucid
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Plaque Risk Stratification Using Routinely Available CCTA to Optimize Therapeutic Decision-making in Patients with Known or Suspected Coronary Artery Disease$1,011,405
R44 · FY2020 · HL
Plaque Risk Stratification Using Routinely Available CCTA to Optimize Therapeutic Decision-making in Patients with Known or Suspected Coronary Artery Disease$991,516
R44 · FY2019 · HL
Plaque Risk Stratification Using Routinely Available CCTA to Optimize Therapeutic Decision-making in Patients with Known or Suspected Coronary Artery Disease$984,177
R44 · FY2021 · HL
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy$798,841
R44 · FY2015 · HL
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy$783,030
R44 · FY2016 · HL